Middle East & Africa Companion Animal Healthcare Market, by Pharmaceuticals, 2018-2027

Growth Outlook

• The 2027 portion of the Middle East & Africa Companion Animal Healthcare Market, by Pharmaceuticals, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 2280 Mn in 2026 and is projected to reach USD 2486 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
• What the regional split looks like (2026): Anti-Infectives leads, holding roughly 33% of segment value — the single largest regional share. Others is the second-largest contributor. Antibiotics and Anti-Inflammatories make up the remainder, in descending order.
• By 2027, Anti-Infectives alone is expected to reach USD 806 Mn, with Others at USD 631 Mn.

Market Dynamics

The Middle East and Africa Companion Animal Healthcare Market has been witnessing steady growth in recent years. This can be attributed to the increasing awareness about animal health, growing pet ownership, and rising spending on pet care in the region. In addition, the advancement in technology and the development of veterinary pharmaceuticals have also contributed to the growth of the market.

Pharmaceuticals are the primary segment in the Companion Animal Healthcare Market in the Middle East and Africa region. The demand for these products is expected to remain high in the coming years as pet owners become more conscious about their animal's well-being and are willing to spend more on their healthcare. In addition, the rising prevalence of chronic diseases and the need for proper treatment for pets is driving the growth of this segment.

The pharmaceuticals segment can be further divided into various types of products such as vaccines, parasiticides, anti-infectives, and others. Vaccines, in particular, have witnessed significant growth in demand as they help in preventing various diseases and infections in animals. The rising incidence of diseases and the need for prevention has led to an increase in the usage of vaccines in the region.

Parasiticides are another crucial product in the pharmaceuticals segment. These products are used for the prevention and treatment of parasitic infections in animals. With the increasing awareness about the importance of regular parasite control, the demand for parasiticides is expected to grow in the coming years.

Anti-infectives, on the other hand, are used for the treatment of infectious diseases in animals. With the rising prevalence of diseases such as rabies and distemper, the demand for anti-infectives is expected to increase in the coming years.

Apart from these, other pharmaceutical products such as anti-inflammatory drugs, pain management medications, and dietary supplements are also gaining traction in the market. These products help in improving the overall health and well-being of animals and are expected to witness significant growth in demand in the forecast period.

In conclusion, the Companion Animal Healthcare Market in the Middle East and Africa region is driven by the increasing demand for pharmaceutical products. With the growing awareness about animal health and the availability of advanced veterinary medicines, the market is expected to witness steady growth in the coming years.